These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38886114)

  • 1. EBV promotes TCR-T-cell therapy resistance by inducing CD163+M2 macrophage polarization and MMP9 secretion.
    Chen Y; Ouyang D; Wang Y; Pan Q; Zhao J; Chen H; Yang X; Tang Y; Wang Q; Li Y; He J; You JQ; Li Y; Xu C; Ren Y; Xie S; Li S; Lian J; Weng D; Xiang T; Xia JC
    J Immunother Cancer; 2024 Jun; 12(6):. PubMed ID: 38886114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat diffuse large B-cell lymphoma of the elderly.
    Poles WA; Nishi EE; de Oliveira MB; Eugênio AIP; de Andrade TA; Campos AHFM; de Campos RR; Vassallo J; Alves AC; Scapulatempo Neto C; Paes RAP; Landman G; Zerbini MCN; Colleoni GWB
    Cancer Immunol Immunother; 2019 Feb; 68(2):269-282. PubMed ID: 30430204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages.
    Yamaguchi Y; Gibson J; Ou K; Lopez LS; Ng RH; Leggett N; Jonsson VD; Zarif JC; Lee PP; Wang X; Martinez C; Dorff TB; Forman SJ; Priceman SJ
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35738799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBV-associated epithelial cancers cells promote vasculogenic mimicry formation via a secretory cross-talk with the immune microenvironment.
    Xiang T; Sun F; Liu T; Zhao J; Yang J; Ouyang D; Chen H; Zhu Q; Wang Q; Li Y; He J; Yang C; Yang X; Chen Y; Tang Y; Weng D; Pan Q; Yang Q; Xia J
    Theranostics; 2024; 14(13):5123-5140. PubMed ID: 39267775
    [No Abstract]   [Full Text] [Related]  

  • 5. Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus-Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma.
    Zheng Y; Parsonage G; Zhuang X; Machado LR; James CH; Salman A; Searle PF; Hui EP; Chan AT; Lee SP
    Cancer Immunol Res; 2015 Oct; 3(10):1138-47. PubMed ID: 25711537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival.
    Barros MH; Segges P; Vera-Lozada G; Hassan R; Niedobitek G
    PLoS One; 2015; 10(5):e0124531. PubMed ID: 25978381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M2-polarized tumour-associated macrophages in stroma correlate with poor prognosis and Epstein-Barr viral infection in nasopharyngeal carcinoma.
    Huang H; Liu X; Zhao F; Lu J; Zhang B; Peng X; Zhang M; Chen X; Li G; Li X
    Acta Otolaryngol; 2017 Aug; 137(8):888-894. PubMed ID: 28395580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma.
    Hu JM; Liu K; Liu JH; Jiang XL; Wang XL; Chen YZ; Li SG; Zou H; Pang LJ; Liu CX; Cui XB; Yang L; Zhao J; Shen XH; Jiang JF; Liang WH; Yuan XL; Li F
    Oncotarget; 2017 Mar; 8(13):21526-21538. PubMed ID: 28423526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD163(+) M2-type tumor-associated macrophage support the suppression of tumor-infiltrating T cells in osteosarcoma.
    Han Q; Shi H; Liu F
    Int Immunopharmacol; 2016 May; 34():101-106. PubMed ID: 26938675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of tumour-associated macrophages and regulatory T cells in EBV-positive and EBV-negative nasopharyngeal carcinoma.
    Ooft ML; van Ipenburg JA; Sanders ME; Kranendonk M; Hofland I; de Bree R; Koljenović S; Willems SM
    J Clin Pathol; 2018 Mar; 71(3):267-274. PubMed ID: 28877959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies.
    Ahmed M; Lopez-Albaitero A; Pankov D; Santich BH; Liu H; Yan S; Xiang J; Wang P; Hasan AN; Selvakumar A; O'Reilly RJ; Liu C; Cheung NV
    JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M1 Macrophage Polarization Prevails in Epstein-Barr Virus-Infected Children in an Immunoregulatory Environment.
    Moyano A; Ferressini Gerpe NM; De Matteo E; Preciado MV; Chabay P
    J Virol; 2022 Jan; 96(1):e0143421. PubMed ID: 34643432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus infection induces indoleamine 2,3-dioxygenase expression in human monocyte-derived macrophages through p38/mitogen-activated protein kinase and NF-κB pathways: impairment in T cell functions.
    Liu WL; Lin YH; Xiao H; Xing S; Chen H; Chi PD; Zhang G
    J Virol; 2014 Jun; 88(12):6660-71. PubMed ID: 24696473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I Clinical Trial of 4-1BB-based Adoptive T-Cell Therapy for Epstein-Barr Virus (EBV)-positive Tumors.
    Eom HS; Choi BK; Lee Y; Lee H; Yun T; Kim YH; Lee JJ; Kwon BS
    J Immunother; 2016 Apr; 39(3):140-8. PubMed ID: 26938947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Epstein-Barr virus latent membrane protein 2 specific T-cell receptors driven by T-cell specific promoters using lentiviral vector.
    Yang D; Shao Q; Sun H; Mu X; Gao Y; Jiang R; Hou J; Yao K; Chen Y; Sun B
    Clin Dev Immunol; 2011; 2011():716926. PubMed ID: 21969838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abundance of CD163-Positive Tumor-Associated Macrophages in the Early Gastric Cancer Predicts the Recurrence after Curative Resection.
    Zhou W; Zhang Y; He F; Lv S; Zhang X; Fei C
    Dig Dis; 2020; 38(6):458-465. PubMed ID: 32721976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
    Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L
    Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Off-the-shelf' allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies.
    Sinha D; Srihari S; Beckett K; Le Texier L; Solomon M; Panikkar A; Ambalathingal GR; Lekieffre L; Crooks P; Rehan S; Neller MA; Smith C; Khanna R
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M2-like macrophage polarization in high lactic acid-producing head and neck cancer.
    Ohashi T; Aoki M; Tomita H; Akazawa T; Sato K; Kuze B; Mizuta K; Hara A; Nagaoka H; Inoue N; Ito Y
    Cancer Sci; 2017 Jun; 108(6):1128-1134. PubMed ID: 28370718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV
    Hernández DM; Valderrama S; Gualtero S; Hernández C; López M; Herrera MV; Solano J; Fiorentino S; Quijano S
    Front Immunol; 2018; 9():2291. PubMed ID: 30337929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.